Maximus cuts tirzepatide plan rates by up to $80 a month; compounded semaglutide no longer listed
Event date 26 Oct 2026 source Maximus
We track prices, terms and availability. We are not clinicians, this page is not medically reviewed, and nothing here is medical advice. Talk to a licensed clinician about whether a GLP-1 medication is right for you.
What changed
At our 15 October 2026 check, Maximus charged $249.99, $219.99, $199.99 and $149.99 a month for its 2-, 4-, 6- and 12-month compounded tirzepatide plans. At our 26 October check the same plans cost $199.99, $149.99, $119.99 and $99.99. That day its semaglutide page redirected to its general weight-loss page, and no page we read listed compounded semaglutide.
Source: Maximus (opens in a new tab)
What it means
Maximus bills each plan up front for the whole term. At the 26 October rates that is $1,199.88 at sign-up for the 12-month plan, down from $1,799.88, and $399.98 for the 2-month plan, down from $499.98. A Maximus product page we read on 23 August 2026 said it does not refund medicines that have been shipped. We have not established whether that still applies, or whether Maximus refunds the unshipped part of a prepaid term, so check its current terms before you pay up front. If you get compounded semaglutide from Maximus now, ask it whether your existing service is affected.
Providers affected
- Maximus FDA warning letter8 Jun 2026
Each plan's figure and the date we read it are on our Maximus review. Our tirzepatide cost guide sets Maximus against the other tirzepatide programs we track.
If you are moving providers, start with our switching guide. Every price change we log is in the change log.